- Home
- MDXH vs MNOV Comparison
MDXH vs MNOV Comparison
Compare MDXH & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- MNOV
- Stock Information
- Founded
- MDXH 2003
- MNOV 2000
- Country
- MDXH Belgium
- MNOV United States
- Employees
- MDXH N/A
- MNOV N/A
- Industry
- MDXH
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- MDXH
- MNOV Health Care
- Exchange
- MDXH Nasdaq
- MNOV Nasdaq
- Market Cap
- MDXH 84.6M
- MNOV 68.2M
- IPO Year
- MDXH 2021
- MNOV 2005
- Fundamental
- Price
- MDXH $2.18
- MNOV $1.27
- Analyst Decision
- MDXH Buy
- MNOV Strong Buy
- Analyst Count
- MDXH 1
- MNOV 2
- Target Price
- MDXH $6.00
- MNOV $7.00
- AVG Volume (30 Days)
- MDXH 61.1K
- MNOV 17.6K
- Earning Date
- MDXH 08-20-2025
- MNOV 08-07-2025
- Dividend Yield
- MDXH N/A
- MNOV N/A
- EPS Growth
- MDXH N/A
- MNOV N/A
- EPS
- MDXH N/A
- MNOV N/A
- Revenue
- MDXH $94,507,000.00
- MNOV N/A
- Revenue This Year
- MDXH $23.51
- MNOV N/A
- Revenue Next Year
- MDXH $17.68
- MNOV N/A
- P/E Ratio
- MDXH N/A
- MNOV N/A
- Revenue Growth
- MDXH 25.46
- MNOV N/A
- 52 Week Low
- MDXH $1.35
- MNOV $1.12
- 52 Week High
- MDXH $3.50
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- MDXH 52.06
- MNOV 40.89
- Support Level
- MDXH $2.09
- MNOV $1.32
- Resistance Level
- MDXH $2.22
- MNOV $1.38
- Average True Range (ATR)
- MDXH 0.10
- MNOV 0.05
- MACD
- MDXH -0.01
- MNOV -0.00
- Stochastic Oscillator
- MDXH 59.52
- MNOV 15.38
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.